Testing effectiveness (Phase 2)Ended earlyNCT00664378What this trial is testingEfficacy Study of CYT997 in Multiple MyelomaWho this might be right forRelapsed and Refractory Multiple Myeloma Gilead Sciences 5
Early research (Phase 1)Ended earlyNCT05712278What this trial is testingInvestigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukaemia Sanofi 7
Early research (Phase 1)Not Yet RecruitingNCT07367685What this trial is testingClinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell LymphomaWho this might be right forRecurrent/Refractory B-cell Lymphoma The Second Affiliated Hospital of Fujian Medical University 6
Early research (Phase 1)Ended earlyNCT03220347What this trial is testingAssess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's LymphomasWho this might be right forLymphoma, Non-HodgkinNeoplasms Celgene 139
Not applicableStudy completedNCT01618747What this trial is testingAn Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second RelapseWho this might be right forGlioblastoma Multiforme Hoffmann-La Roche 20
Large-scale testing (Phase 3)Study completedNCT00668343What this trial is testingSimvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to PlaceboWho this might be right forRelapsing Remitting Multiple Sclerosis Tehran University of Medical Sciences 80
Testing effectiveness (Phase 2)Study completedNCT01138904What this trial is testingFOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)Who this might be right forGastric Cancer Dong-A University Hospital 80
Early research (Phase 1)Study completedNCT05225584What this trial is testingSafety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid TumorsWho this might be right forNon Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more Kymera Therapeutics, Inc. 56
Early research (Phase 1)Active Not RecruitingNCT05878184What this trial is testingStudy Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)Who this might be right forNon Hodgkin LymphomaChronic Lymphocytic Leukemia Sana Biotechnology 16
Early research (Phase 1)Study completedNCT03013933What this trial is testingBrentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin LymphomaWho this might be right forRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma City of Hope Medical Center 29
Not applicableEnded earlyNCT01517347What this trial is testingEfficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After TransplantationWho this might be right forLeukemia Peking University People's Hospital 90
Testing effectiveness (Phase 2)Study completedNCT03439293What this trial is testingIxazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma Takeda 61
Testing effectiveness (Phase 2)WithdrawnNCT00845104What this trial is testingFludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWho this might be right forB-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)UnknownNCT03940833What this trial is testingClinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MMWho this might be right forMultiple Myeloma Asclepius Technology Company Group (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752What this trial is testingCLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell TransplantationWho this might be right forLeukemia Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00866138What this trial is testingMasitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3Who this might be right forMultiple Myeloma AB Science 24
Early research (Phase 1)Looking for participantsNCT06191978What this trial is testingA Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT02927964What this trial is testingTLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular LymphomaWho this might be right forGrade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+4 more Robert Lowsky 21
Early research (Phase 1)Ended earlyNCT06163898What this trial is testingEvaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 4
Large-scale testing (Phase 3)Study completedNCT00117598What this trial is testingStudy Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)Who this might be right forLymphoma Pfizer 169